Abstract
Chronic cavitary pulmonary histoplasmosis requires prolonged treatment with itraconazole. However, hypersensitivity reactions to itraconazole, though rare, pose a challenge due to limited data on the efficacy and cross-reactivity of the newer azoles. We present a case of chronic cavitary pulmonary histoplasmosis successfully treated with isavuconazole following an itraconazole-induced hypersensitivity reaction, highlighting its potential as an alternative therapy in such cases.
| Original language | English (US) |
|---|---|
| Article number | 100711 |
| Journal | Medical Mycology Case Reports |
| Volume | 49 |
| DOIs | |
| State | Published - Sep 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cross-reaction
- Histoplasmosis
- Hypersensitivity
- Isavuconazole
- Itraconazole
ASJC Scopus subject areas
- Microbiology
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Chronic cavitary pulmonary histoplasmosis treated with isavuconazole after a hypersensitivity reaction to itraconazole'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS